CA Stock MarketDetailed Quotes

NGMD NuGen Medical Devices Inc

Watchlist
  • 0.100
  • -0.010-9.09%
15min DelayMarket Closed Nov 15 16:00 ET
21.77MMarket Cap-3125P/E (TTM)

NuGen Medical Devices Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
91.45%-214.56K
60.28%-813.44K
-215.07%-6.71M
-671.93%-1.2M
-256.15%-959.88K
-299.85%-2.51M
-89.82%-2.05M
47.96%-2.13M
94.17%-155.1K
47.01%-269.51K
Net income from continuing operations
60.29%-950.87K
13.48%-1.83M
-67.84%-9.36M
-47.43%-2.57M
-147.02%-2.28M
-69.25%-2.39M
-41.38%-2.11M
21.52%-5.58M
51.22%-1.75M
29.11%-924.1K
Operating gains losses
-2,764.96%-487.24K
-65.64%35.83K
--64.53K
----
----
89.73%-17.01K
501.22%104.28K
----
----
----
Depreciation and amortization
-10.52%159.89K
-4.80%172.28K
5.89%690.84K
-19.25%152.69K
2.94%178.5K
28.92%178.69K
19.61%180.96K
-17.48%652.4K
-39.49%189.09K
9.94%173.4K
Remuneration paid in stock
--0
-91.12%50.51K
215.92%1.36M
128.39%443.5K
21,961.21%47.21K
267.36%304.14K
268.22%569.12K
-66.99%431.75K
-85.16%194.18K
--214
Deferred tax
----
----
963.10%33.8K
1,904.09%25.47K
2,554.29%859
----
----
7.54%3.18K
-57.00%1.27K
---35
Other non cashItems
136.20%765.56K
-7.36%306.87K
-30.13%1.23M
-20.15%214.49K
-53.63%359.19K
0.49%324.12K
-15.76%331.26K
53.16%1.76M
-50.98%268.62K
48,782.72%774.54K
Change In working capital
132.70%298.1K
139.85%447.42K
-220.20%-725.79K
-49.28%476.26K
272.28%832.49K
-322.80%-911.65K
-329.95%-1.12M
364.98%603.8K
163.51%939.04K
-179.18%-483.23K
-Change in receivables
-47.54%52.1K
400.01%246.58K
-255.14%-96.83K
173.79%27.46K
-161.65%-141.41K
355.94%99.31K
9.63%-82.19K
139.54%62.42K
40.58%-37.21K
326.73%229.38K
-Change in inventory
-4,300.24%-345.9K
260.12%21.47K
-107.46%-132.51K
-104.61%-125.63K
13.26%-4.99K
-752.60%-7.86K
42.11%5.96K
-1,904.83%-63.87K
-897.17%-61.4K
-444.02%-5.75K
-Change in prepaid assets
104.21%23.51K
115.64%120.35K
-212.60%-135.23K
74.69%430.41K
314.35%762.73K
-548.47%-558.67K
-1,218.45%-769.7K
-31.14%-43.26K
514.11%246.38K
-3,684.51%-355.83K
-Change in payables and accrued expense
127.23%146.13K
126.73%74.19K
-161.58%-376.73K
-73.67%198.64K
156.07%238.87K
-234.39%-536.64K
-139.23%-277.6K
1,908.47%611.73K
147.15%754.47K
-160.87%-426.02K
-Change in other working capital
357.91%422.26K
-2,486.79%-15.18K
-57.81%15.52K
---54.61K
---22.72K
--92.22K
--636
--36.79K
----
----
Tax refund paid
----
----
-161.81%-8.32K
100.08%1
----
----
----
-7.54%-3.18K
---1.27K
----
Cash from discontinued investing activities
Operating cash flow
91.45%-214.56K
60.28%-813.44K
-215.07%-6.71M
-671.93%-1.2M
-256.22%-960.06K
-299.82%-2.51M
-89.82%-2.05M
47.96%-2.13M
94.18%-155.1K
46.50%-269.51K
Investing cash flow
Cash flow from continuing investing activities
-375
-375
-5,202.58%-53.4K
-53.4K
0
0
0
-158.61%-1.01K
0
Net PPE purchase and sale
----
----
-200.10%-3.02K
---3.02K
----
----
----
71.82%-1.01K
--0
----
Net other investing changes
---375
---375
---50.38K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---375
---375
-5,202.58%-53.4K
---53.4K
--0
--0
--0
-158.61%-1.01K
--0
----
Financing cash flow
Cash flow from continuing financing activities
-100.21%-7.03K
-68.53%744.23K
1,282.02%7.1M
-46.58%49.97K
213.98%1.32M
4,388.53%3.37M
3,252.93%2.36M
-90.80%513.78K
-97.78%93.54K
-26.95%420.24K
Net issuance payments of debt
99.14%-7.03K
34.90%-20.77K
-938.64%-871.28K
131.69%9.97K
---30.52K
---818.83K
---31.9K
-211.85%-83.89K
-25.83%-31.46K
----
Net common stock issuance
--0
--0
878.17%6.58M
--0
--0
--4.18M
--2.4M
-87.79%672.67K
-97.05%125K
15.23%547.67K
Proceeds from stock option exercised by employees
--0
--765K
--1.39M
--40K
--1.35M
--2K
--0
--0
--0
----
Net other financing activities
----
----
----
----
----
----
----
---75K
--0
----
Cash from discontinued financing activities
Financing cash flow
-100.21%-7.03K
-68.53%744.23K
1,282.02%7.1M
-46.58%49.97K
213.98%1.32M
4,388.53%3.37M
3,252.93%2.36M
-90.80%513.78K
-97.78%93.54K
-26.95%420.24K
Net cash flow
Beginning cash position
-12.85%394.88K
253.33%464.46K
-92.49%131.45K
762.74%1.67M
1,343.58%1.26M
-25.14%453.09K
-92.49%131.45K
533.15%1.75M
-1.17%193.01K
-29.89%87.48K
Current changes in cash
-125.88%-221.96K
-121.98%-69.58K
120.58%333.01K
-1,850.59%-1.2M
140.07%359.42K
255.24%857.67K
127.44%316.6K
-208.58%-1.62M
-103.95%-61.56K
109.40%149.72K
Effect of exchange rate changes
--0
--0
--0
--0
196.97%42.86K
-238.11%-47.89K
-47.06%5.04K
--0
--0
-4,391.36%-44.2K
End cash Position
-86.31%172.92K
-12.85%394.88K
253.33%464.46K
253.33%464.46K
762.74%1.67M
1,343.58%1.26M
-25.14%453.09K
-92.49%131.45K
-92.49%131.45K
-1.17%193.01K
Free cash from
91.45%-214.56K
60.28%-813.44K
-215.06%-6.72M
-673.88%-1.2M
-254.89%-960.06K
-299.82%-2.51M
-89.82%-2.05M
47.99%-2.13M
94.18%-155.1K
46.30%-270.52K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 91.45%-214.56K60.28%-813.44K-215.07%-6.71M-671.93%-1.2M-256.15%-959.88K-299.85%-2.51M-89.82%-2.05M47.96%-2.13M94.17%-155.1K47.01%-269.51K
Net income from continuing operations 60.29%-950.87K13.48%-1.83M-67.84%-9.36M-47.43%-2.57M-147.02%-2.28M-69.25%-2.39M-41.38%-2.11M21.52%-5.58M51.22%-1.75M29.11%-924.1K
Operating gains losses -2,764.96%-487.24K-65.64%35.83K--64.53K--------89.73%-17.01K501.22%104.28K------------
Depreciation and amortization -10.52%159.89K-4.80%172.28K5.89%690.84K-19.25%152.69K2.94%178.5K28.92%178.69K19.61%180.96K-17.48%652.4K-39.49%189.09K9.94%173.4K
Remuneration paid in stock --0-91.12%50.51K215.92%1.36M128.39%443.5K21,961.21%47.21K267.36%304.14K268.22%569.12K-66.99%431.75K-85.16%194.18K--214
Deferred tax --------963.10%33.8K1,904.09%25.47K2,554.29%859--------7.54%3.18K-57.00%1.27K---35
Other non cashItems 136.20%765.56K-7.36%306.87K-30.13%1.23M-20.15%214.49K-53.63%359.19K0.49%324.12K-15.76%331.26K53.16%1.76M-50.98%268.62K48,782.72%774.54K
Change In working capital 132.70%298.1K139.85%447.42K-220.20%-725.79K-49.28%476.26K272.28%832.49K-322.80%-911.65K-329.95%-1.12M364.98%603.8K163.51%939.04K-179.18%-483.23K
-Change in receivables -47.54%52.1K400.01%246.58K-255.14%-96.83K173.79%27.46K-161.65%-141.41K355.94%99.31K9.63%-82.19K139.54%62.42K40.58%-37.21K326.73%229.38K
-Change in inventory -4,300.24%-345.9K260.12%21.47K-107.46%-132.51K-104.61%-125.63K13.26%-4.99K-752.60%-7.86K42.11%5.96K-1,904.83%-63.87K-897.17%-61.4K-444.02%-5.75K
-Change in prepaid assets 104.21%23.51K115.64%120.35K-212.60%-135.23K74.69%430.41K314.35%762.73K-548.47%-558.67K-1,218.45%-769.7K-31.14%-43.26K514.11%246.38K-3,684.51%-355.83K
-Change in payables and accrued expense 127.23%146.13K126.73%74.19K-161.58%-376.73K-73.67%198.64K156.07%238.87K-234.39%-536.64K-139.23%-277.6K1,908.47%611.73K147.15%754.47K-160.87%-426.02K
-Change in other working capital 357.91%422.26K-2,486.79%-15.18K-57.81%15.52K---54.61K---22.72K--92.22K--636--36.79K--------
Tax refund paid ---------161.81%-8.32K100.08%1-------------7.54%-3.18K---1.27K----
Cash from discontinued investing activities
Operating cash flow 91.45%-214.56K60.28%-813.44K-215.07%-6.71M-671.93%-1.2M-256.22%-960.06K-299.82%-2.51M-89.82%-2.05M47.96%-2.13M94.18%-155.1K46.50%-269.51K
Investing cash flow
Cash flow from continuing investing activities -375-375-5,202.58%-53.4K-53.4K000-158.61%-1.01K0
Net PPE purchase and sale ---------200.10%-3.02K---3.02K------------71.82%-1.01K--0----
Net other investing changes ---375---375---50.38K----------------------------
Cash from discontinued investing activities
Investing cash flow ---375---375-5,202.58%-53.4K---53.4K--0--0--0-158.61%-1.01K--0----
Financing cash flow
Cash flow from continuing financing activities -100.21%-7.03K-68.53%744.23K1,282.02%7.1M-46.58%49.97K213.98%1.32M4,388.53%3.37M3,252.93%2.36M-90.80%513.78K-97.78%93.54K-26.95%420.24K
Net issuance payments of debt 99.14%-7.03K34.90%-20.77K-938.64%-871.28K131.69%9.97K---30.52K---818.83K---31.9K-211.85%-83.89K-25.83%-31.46K----
Net common stock issuance --0--0878.17%6.58M--0--0--4.18M--2.4M-87.79%672.67K-97.05%125K15.23%547.67K
Proceeds from stock option exercised by employees --0--765K--1.39M--40K--1.35M--2K--0--0--0----
Net other financing activities -------------------------------75K--0----
Cash from discontinued financing activities
Financing cash flow -100.21%-7.03K-68.53%744.23K1,282.02%7.1M-46.58%49.97K213.98%1.32M4,388.53%3.37M3,252.93%2.36M-90.80%513.78K-97.78%93.54K-26.95%420.24K
Net cash flow
Beginning cash position -12.85%394.88K253.33%464.46K-92.49%131.45K762.74%1.67M1,343.58%1.26M-25.14%453.09K-92.49%131.45K533.15%1.75M-1.17%193.01K-29.89%87.48K
Current changes in cash -125.88%-221.96K-121.98%-69.58K120.58%333.01K-1,850.59%-1.2M140.07%359.42K255.24%857.67K127.44%316.6K-208.58%-1.62M-103.95%-61.56K109.40%149.72K
Effect of exchange rate changes --0--0--0--0196.97%42.86K-238.11%-47.89K-47.06%5.04K--0--0-4,391.36%-44.2K
End cash Position -86.31%172.92K-12.85%394.88K253.33%464.46K253.33%464.46K762.74%1.67M1,343.58%1.26M-25.14%453.09K-92.49%131.45K-92.49%131.45K-1.17%193.01K
Free cash from 91.45%-214.56K60.28%-813.44K-215.06%-6.72M-673.88%-1.2M-254.89%-960.06K-299.82%-2.51M-89.82%-2.05M47.99%-2.13M94.18%-155.1K46.30%-270.52K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data